In prostate cancer, androgens—through activation of their receptor AR—have also been shown to be major orchestrators of specific metabolic pathways, such as mitochondrial respiration, lipid synthesis and usage, and glycolysis modulation (4, 20, 21, 41–43). Here, AR is linked to prostate carcinoma.